Klaudia Széphelyi

Ms. Klaudia Széphelyi

Doctoral School of Health Sciences, University of Pecs, Pécs, Baranya, Hungary
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2024 in Robotics
Verified
Journal Article
Open access
PDF file
SKSzilvia Kóra
Szilvia Kóra
ABAdrienn Bíró
Adrienn Bíró
NPNándor Prontvai
Nándor Prontvai
MAMónika Androsics
Mónika Androsics
IDIstván Drotár
István Drotár
József TollárJózsef Tollár
József Tollár
Medical robotics nowadays can prevent, treat, or alleviate numerous severe conditions, including the dire consequences of stroke. Our objective was to determine the effect of employing a robotic soft exoskeleton in therapy on the development of the early mobilization, gait, and coordination in stroke patients. The ReStore™ Soft Exo-Suit, a wearable exosuit developed by a leading company with exoskeleton technology, was utilized. It is a powered, lightweight device intended for use in stroke rehabilitation for people with lower limb disability. We performed a randomized clinical intervention, using a before–after trial design in a university hospital setting. A total of 48 patients with a history of stroke were included, of whom 39 were randomized and 30 completed the study. Interventions: Barthel Index and modified Rankin scale (mRS) patients were randomly assigned to a non-physical intervention control (n = 9 of 39 completed, 30 withdrew before baseline testing), or to a high-intensity agility program (15 sessions, 5 weeks, n = 30 completed). The main focus of assessment was on the Modified Rankin Scale. Additionally, we evaluated secondary factors including daily life functionality, five dimensions of health-related quality of life, the Beck depression inventory, the 6 min walk test (6MWT), the Berg Balance Scale (BBS), and static balance (center of pressure). The Robot-Assisted Gait Therapy (ROB/RAGT) program led to significant improvements across various measures, including a 37% improvement in Barthel Index scores, a 56% increase in 10 m walking speed, and a 68% improvement in 6 min walking distance, as well as notable enhancements in balance and stability. Additionally, the intervention group demonstrated significant gains in all these aspects compared to the control group. In conclusion, the use of robotic therapy can be beneficial in stroke rehabilitation. These devices support the restoration and improvement of movement in various ways and contribute to restoring balance and stability.

26 March 2025 in Neurology International
Verified
Journal Article
Open access
PDF file
Klaudia SzéphelyiKlaudia Széphelyi
Klaudia Széphelyi
SKSzilvia Kóra
Szilvia Kóra
GOGergely Orsi
Gergely Orsi
József TollárJózsef Tollár
József Tollár
Background/Objectives: Headache is one of the most common neurological symptoms associated with COVID-19, affecting approximately 25% of patients. While most headaches resolve within weeks, some persist for months, suggesting underlying structural brain changes. This study aimed to identify brain MRI abnormalities associated with chronic headaches in patients with a history of COVID-19 infection. Methods: This retrospective study included 30 patients with post-COVID-19 headaches and 30 control patients with no history of COVID-19. Demographic characteristics were analyzed using t-tests and chi-square tests. MRI findings were categorized into six types: cortical atrophy, white matter lesions, vascular lesions, lacunar lesions, vascular encephalopathy, and sinusitis. Differences in MRI findings between the two groups were evaluated using chi-square tests. Secondary outcomes included the analysis of symptoms accompanying headaches, diagnoses following MRI, and treatments applied. Results: White matter lesions were significantly more frequent in the post-COVID-19 group (50%) compared to controls (20%) (p = 0.015). Conversely, sinusitis was more prevalent in the control group (36.7%) than in the post-COVID-19 group (6.7%) (p = 0.005). Other MRI abnormalities showed no significant differences. Cognitive dysfunction (30%) and dizziness (33.3%) were the most common associated symptoms. The most frequent diagnoses after MRI in the post-COVID-19 group were headaches/migraines (23.3%), post-COVID-19 headache (20%), and vestibular syndrome (13.3%). Conclusions: Persistent post-COVID-19 headaches may be linked to structural white matter changes observed in MRI. Further research, ideally including pre-infection imaging data, is needed to determine the causal relationship between these lesions and chronic headache symptoms. Trial Registration: This study was registered in ClinicalTrials with the trial registration number NCT06825741 on 13 February 2025.

10 September 2025 in Neurology International
Verified
Journal Article
Open access
PDF file
Klaudia SzéphelyiKlaudia Széphelyi
Klaudia Széphelyi
SKSzilvia Kóra
Szilvia Kóra
GOGergely Orsi
Gergely Orsi
József TollárJózsef Tollár
József Tollár
Background/Objectives: Dizziness is a frequent medical complaint with neurological, otolaryngological, and psychological origins. Imaging studies such as CT (Computer Tomography), cervical X-rays, and ultrasound aid diagnosis, while MRI (Magnetic Resonance Imaging) is crucial for detecting brain abnormalities. Our purpose is to identify structural brain changes associated with vertigo, assess pre-MRI diagnostic approaches, and evaluate treatment strategies. Methods: A case-control study of 232 vertigo patients and 232 controls analyzed MRI findings, pre-MRI examinations, symptoms, and treatments. Statistical comparisons were performed using chi-square and t-tests (p < 0.05). Results: White matter lesions, lacunar infarcts, Circle of Willis variations, and sinusitis were significantly more frequent in vertigo patients (p < 0.05). Pre-MRI diagnostics frequently identified atherosclerosis (ultrasound) and spondylosis (X-ray). Common symptoms included headache, imbalance, and visual disturbances. The most frequent post-MRI diagnosis was Benign Paroxysmal Positional Vertigo (BPPV). Treatments included lifestyle modifications, physical therapy (e.g., Epley maneuver), and pharmacological therapies such as betahistine. Conclusions: MRI revealed structural brain changes linked to vertigo. Pre-MRI assessments are essential for ruling out vascular and musculoskeletal causes. A multidisciplinary treatment approach is recommended. Trial Registration: This study was registered in ClinicalTrials.gov with the trial registration number NCT06848712 on 22 February 2025.

29 July 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
Klaudia SzéphelyiKlaudia Széphelyi
Klaudia Széphelyi
ABAdrienn Biró
Adrienn Biró
JTJózsef Tollár
József Tollár
Introduction: The COVID-19 pandemic was associated with substantial changes in cancer diagnosis and treatment. This study aimed to assess changes in colorectal cancer diagnostics during the COVID-19 pandemic by analyzing changes in tumor stage and the number of newly diagnosed cases across different pandemic waves and the post-COVID period using MRI-based data. Methods: The study included 198 patients with colorectal cancer, 43 with a new diagnosis. The study period was divided into five COVID-19–related intervals. The number of newly diagnosed cases across COVID-19 waves was compared using one-way ANOVA. Stage distribution differences were assessed using Fisher’s exact test. In follow-up patients, changes were analyzed using the Wilcoxon signed-rank test. Secondary outcomes included tumor changes, number of missed treatments, and the presence of metastases. Results: Monthly averages of newly diagnosed colorectal cancer cases were lower during the COVID-19 waves than in the post-COVID period (p < 0.001). Although overall tumor stage did not differ between waves, larger tumors were more frequent during the COVID-19 waves, whereas early-stage (T1) tumors were more common in the late/post-COVID period (p < 0.001). Tumor stage distribution also differed between the COVID and post-COVID periods, with a shift toward earlier-stage disease after the pandemic (p = 0.002). No differences were observed in missed treatments across COVID-19 periods (p-value > 0.05). Discussion: The COVID-19 pandemic was associated with a lower number of newly diagnosed colorectal cancer cases during the pandemic and a higher proportion of patients presenting with more advanced disease stages. These findings suggest an association with pandemic-related healthcare disruption; however, causality cannot be established. Trial registration: https://clinicaltrials.gov/ , identifier NCT07328399.